Deletion of Vaccinia Virus A40R Gene Improves the Immunogenicity of the HIV-1 Vaccine Candidate MVA-B

por Pérez, Patricia, Marín, María Q., Lázaro-Frías, Adrián, Sorzano, Carlos Óscar S., Gómez, Carmen E., Esteban, Mariano, García-Arriaza, Juan
Publicado 2020

An MVA Vector Expressing HIV-1 Envelope under the Control of a Potent Vaccinia Virus Promoter as a Promising Strategy in HIV/AIDS Vaccine Design

por Pérez, Patricia, Marín, María Q., Lázaro-Frías, Adrián, Sorzano, Carlos Óscar S., Di Pilato, Mauro, Gómez, Carmen E., Esteban, Mariano, García-Arriaza, Juan
Publicado 2019

The combined vaccination protocol of DNA/MVA expressing Zika virus structural proteins as efficient inducer of T and B cell immune responses

por Pérez, Patricia, Martín-Acebes, Miguel A., Poderoso, Teresa, Lázaro-Frías, Adrián, Saiz, Juan-Carlos, Sorzano, Carlos Óscar S., Esteban, Mariano, García-Arriaza, Juan
Publicado 2021

Full efficacy and long-term immunogenicity induced by the SARS-CoV-2 vaccine candidate MVA-CoV2-S in mice

por Lázaro-Frías, Adrián, Pérez, Patricia, Zamora, Carmen, Sánchez-Cordón, Pedro J., Guzmán, María, Luczkowiak, Joanna, Delgado, Rafael, Casasnovas, José M., Esteban, Mariano, García-Arriaza, Juan
Publicado 2022

A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection

por Pérez, Patricia, Lázaro-Frías, Adrián, Zamora, Carmen, Sánchez-Cordón, Pedro J., Astorgano, David, Luczkowiak, Joanna, Delgado, Rafael, Casasnovas, José M., Esteban, Mariano, García-Arriaza, Juan
Publicado 2022

COVID-19 Vaccine Candidates Based on Modified Vaccinia Virus Ankara Expressing the SARS-CoV-2 Spike Protein Induce Robust T- and B-Cell Immune Responses and Full Efficacy in Mice

por García-Arriaza, Juan, Garaigorta, Urtzi, Pérez, Patricia, Lázaro-Frías, Adrián, Zamora, Carmen, Gastaminza, Pablo, del Fresno, Carlos, Casasnovas, José M., S. Sorzano, Carlos Óscar, Sancho, David, Esteban, Mariano
Publicado 2021

A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice

por Pérez, Patricia, Q. Marín, María, Lázaro-Frías, Adrián, Jiménez de Oya, Nereida, Blázquez, Ana-Belén, Escribano-Romero, Estela, S. Sorzano, Carlos Óscar, Ortego, Javier, Saiz, Juan-Carlos, Esteban, Mariano, Martín-Acebes, Miguel A., García-Arriaza, Juan
Publicado 2018

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters

por Boudewijns, Robbert, Pérez, Patricia, Lázaro-Frías, Adrián, Van Looveren, Dominique, Vercruysse, Thomas, Thibaut, Hendrik Jan, Weynand, Birgit, Coelmont, Lotte, Neyts, Johan, Astorgano, David, Montenegro, Dolores, Puentes, Eugenia, Rodríguez, Esteban, Dallmeier, Kai, Esteban, Mariano, García-Arriaza, Juan
Publicado 2022

Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2

por Mooij, Petra, García-Arriaza, Juan, Pérez, Patricia, Lázaro-Frías, Adrian, Verstrepen, Babs E., Böszörményi, Kinga P., Mortier, Daniella, Fagrouch, Zahra, Kiemenyi-Kayere, Gwendoline, Niphuis, Henk, Acar, Roja Fidel, Meijer, Lisette, Stammes, Marieke A., Kondova, Ivanela, Verschoor, Ernst J., GeurtsvanKessel, Corine H., de Bruin, Erwin, Sikkema, Reina S., Luczkowiak, Joanna, Delgado, Rafael, Montenegro, Dolores, Puentes, Eugenia, Rodríguez, Esteban, Bogers, Willy M. J. M., Koopman, Gerrit, Esteban, Mariano
Publicado 2022